GAAS/A1GAAS HETEROSTRUCTURE POINT-CONTACT CONCENTRATOR CELLS
Kopin Corporation · National Aeronautics and Space Administration
Phase I1987$50,000
N/A
Public Market Intelligence
Explore federally funded small business innovation research, technology awards, participating companies, and agency investments.
Company count, total reported award value are not available for this view.
Kopin Corporation · National Aeronautics and Space Administration
Phase I1987$50,000
N/A
IONWERKS INC · Department of Health and Human Services
Phase II2005$99,994
L2 DIAGNOSTICS LLC · Department of Health and Human Services
Phase I2008$219,461
DESCRIPTION (provided by applicant): Gliomas are malignant tumors that arise from glial cells in the central nervous system and are among the deadliest of human cancers. These tumors are notorious for their aggressive a…
GEROTECH CORPORATION · Department of Health and Human Services
Phase I2002$99,618
DESCRIPTION (provided by applicant): Adults over age 60 constitute the fastest growing market of Internet users; a common reason for being online is to access health information. However, most web sites are not designed…
STRUCTURED MATERIALS INDUSTRIES, INC. · Department of Commerce
Phase I2006$75,000
As more and more information is stored digitally and transmitted over the Internet, data and communication security becomes an ever more severe problem facing the military, the government and the financial industry, bot…
Ocis Technology LLC · Department of Defense
Phase I2002$69,997
Nitride based semiconductors offer a wide range of electronic and optical properties that will permit greatly improved performance of electronic, photonic and optoelectronic devices and circuits. GaN-based LEDs are now…
VACCINEX, INC. · Department of Health and Human Services
Phase I2001$99,999
DESCRIPTION (Provided by Applicant): Our ability to develop drugs to effectively treat musculoskeletal diseases like osteoarthritis is limited by the absence of drug targets (genes) central to the etiology of these dise…
FERMALOGIC, INC. · Department of Health and Human Services
Phase II1995$749,941
The macrolides are microbial natural products with many uses in clinical and veterinary medicine. Erythromycin is the best studied example of a macrolide antibiotic; rapamycin and FK506 are promising new immunosuppressa…
NEPHROS THERAPEUTICS, INC. · Department of Health and Human Services
Phase I1998$100,000
N/A
ELITRA PHARMACEUTICALS, INC. · Department of Health and Human Services
Phase I2003$109,379
DESCRIPTION (provided by applicant): Discovery and development of new antibiotics is widely recognized as an urgent medical need. However, despite intensive R&D efforts at several major pharmaceutical companies, few pro…
AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC. · Department of Health and Human Services
Phase II2005$1,541,520
DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a long-term, debilitating disorder that causes loss of memory and cognitive functions. There is an urgent need for effective therapeutic agents to amelior…
Excel Superconductors, Inc. · Department of Defense
Phase I1993$50,000
Residual stress in thin-film materials resulting from thermal and chemical strains is a continuing problem in the synthesis of superconducting thin films. The probelm exists not only in the superconducting layers, but a…
Spire Corporation · Department of Defense
Phase I1991$49,936
ONE PROMISING APPROACH TO THE FABRICATION OF LONG-WAVELENGTH INFRARED (LWIR) DETECTORS IS THE USE OF GAAG-A1GAAS MULTIPLE-QUANTUM-WELL (MQW) STRUCTURES, ALTHOUGH A MAJOR DIFFICULTY IS CAUSED BY THE FACT THAT, TO BE DETE…
Orbital Technologies Corporation · National Aeronautics and Space Administration
Phase II2002$599,999
ORBITEC proposes to use ultra-fine aluminum powder (UFAL) to develop a gelled LH2 fuel and LOX propellant system. This innovation will increase the performance and density of LH2/LOX and the combustion efficiency of LH2…
Arcos, Inc. · Department of Health and Human Services
Phase I2014$225,022
DESCRIPTION (provided by applicant): Goal-directed decision support system for treating perioperative fluid deficits Gastro-intestinal, cardiac and orthopedic surgeries can result in significant blood and fluid losses.…
MOLECULAR TOOL, INC. · Department of Health and Human Services
Phase II1998$421,551
N/A
Taiga Biotechnologies, Inc. · Department of Health and Human Services
Phase I2008$161,192
DESCRIPTION (provided by applicant): Using a method of retroviral gene transduction we have been able to generate conditionally immortalized long-term hematopoietic stem cell lines from primary mouse bone marrow stem ce…
Crystal Systems, Inc. · National Science Foundation
Phase I1989$42,073
IT IS NECESSARY TO EVALUATE NEW LASER MATERIALS WITH INCREASED WALL PLUG EFFICIENCY. CURRENTLY SEMICONDUCTOR LASER ARRAYS HOLD THE POTENTIAL TO BE EFFECTIVE OPTICAL PUMPING SOURCES. IN ORDER TO UTILIZE THE SEMICONDUCTOR…
BANDGAP TECHNOLOGIES, INC. · Department of Defense
Phase II2003$750,000
Absence of low defect density large diameter (~100 mm) silicon carbide (SiC) wafers is a major barrier for the commercial production of SiC-based devices. Hence, the development of a process to produce large diameter bu…
LIFETIME PHARMACEUTICAL, INC. · Department of Health and Human Services
Phase I2004$100,000
DESCRIPTION (provided by applicant): Microarray analysis, in combination with new statistical tools, is a powerful technology for studying gene expression. Dr. He has successfully applied this approach in his lab to ana…
SELECTIVE GENETICS, INC. · Department of Health and Human Services
Phase I1999$100,000
Not Available With the high cost and limited flexibility of testing weapon systems in an actual operational (flight, etc.) environment, there are many cost and technical benefits to be obtained by conducting preliminary…
Transgenic Sciences Inc. · Department of Health and Human Services
Phase II1991$467,762
THE WATANABE HERITABLE HYPERLIPIDEMIC (WHHL) RABBIT IS AN EXCELLENT MODEL FOR FAMILIAL HYPERCHOLESTEROLEMIA, A COMMON HUMAN GENETIC DISEASE. THE HIGH COST, LIMITED SUPPLY, AND GENETIC VARIABILITY HAVE RESTRICTED THE POT…
AMETHYST RESEARCH INC · Department of Energy
Phase I2016$224,997
Significant improvements in the technology to monitor greenhouse gases are required. In particular there is need to be able to simultaneously monitor both small (~m) and large area sites (~ 100km) and in rugged/inaccess…
CIENCIA INC · National Aeronautics and Space Administration
Phase II1997$599,958
N/A
RAINBOW ORGANIC FARMS CO · Department of Agriculture
Phase I2014$97,068
A vastly under-served community, located in an impoverished, 1,500-acre tract in the city of St. Louis, Missouri, is in dire need of increased accessibility to nutritious food. Most of the buildings are torn down, decay…
See what leading AI assistants have to say about RFPCapture and CaptureIQ.
Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:
What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.